Showing results (1-10 of 323) with videos related to
Sort By:
Pageof 33
Expert Review of Anti-Infective Therapy|December 14, 2011
Diagnosing acute HIV infectionSabine Yerly, Bernard HirschelAntiviral Therapy|December 3, 2003
Drug resistance mutations during structured treatment interruptionsSabine Yerly, Catherine Fagard, Huldrych F Günthard, et al.Journal of Medical Case Reports|August 24, 2010
Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case reportStephane Emonet, Sarah Dettwiler, Isabelle Der Hagopian, et al.AIDS (London, England)|September 9, 2004
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptionsSabine Yerly, Huldrych F Günthard, Catherine Fagard, et al.AIDS (London, England)|October 12, 2012
Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infectionsJuan Ambrosioni, Thomas Junier, Cécile Delhumeau, et al.AIDS (London, England)|August 31, 2010
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadirChristine Gutmann, Alexia Cusini, Huldrych F Günthard, et al.Dermatology (Basel, Switzerland)|December 2, 2005
Increased incidence of sexually transmitted infections in Geneva, SwitzerlandShahnaz Abraham, Laurence Toutous-Trellu, Marc Pechère, et al.AIDS (London, England)|June 3, 2009
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infectionSabine Yerly, Thomas Junier, Angèle Gayet-Ageron, et al.Expert Review of Anti-Infective Therapy|October 16, 2004
Structured treatment interruptions in HIV infection: benefit or disappointment?Annette Oxenius, Bernard HirschelAIDS (London, England)|December 20, 2007
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort StudyMarcel Wolbers, Milos Opravil, Viktor von Wyl, et al.Pageof 33